FDA Issues Safety Alert on Weight-Loss Drug’s Kidney Risks
The FDA issued a drug safety communication approving a label change that warns about the risk of kidney stones or kidney injury with the over-the-counter (OTC) weight loss drug orlistat…
GLP-1 Drugs Cut Need for Knee Replacement
Weight loss is known to reduce the need for joint replacement surgery in overweight or obese people with knee osteoarthritis (OA), and glucagon-like peptide-1 (GLP-1) receptor agonists are an established…
